“bcr-abl (b3a2)-derived peptide vaccine”的概念、定义、翻译、参考文献-科学参考

A peptide vaccine consisting of the bcr-abl b3a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b3a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b3a2 fusion protein. Fusion genes in CML typically result from the fusion of either BCR exon b2 or BCR exon b3 to ABL exon a2, a 'b3a2' or a 'b2a2' fusion.

单词	bcr-abl (b3a2)-derived peptide vaccine
释义	bcr-abl (b3a2)-derived peptide vaccine A peptide vaccine consisting of the bcr-abl b3a2 fusion oncoprotein, frequently expressed in chronic myelogenous leukemia (CML), with potential antineoplastic activity. Vaccination with the bcr-abl (b3a2)-derived peptide vaccine may stimulate the host immune system to mount a cytotoxic T lymphocyte (CTL) response against tumor cells that express the bcr-abl b3a2 fusion protein. Fusion genes in CML typically result from the fusion of either BCR exon b2 or BCR exon b3 to ABL exon a2, a 'b3a2' or a 'b2a2' fusion.
随便看	mycophenolate mofetil mycophenolic acid mycorrhizae mycosis fungoides mycosis fungoides patch mycosis fungoides plaque Mycostatin MYC-targeting siRNA DCR-MYC myelin myelin sheath myeloablation myeloablative chemotherapy myeloblast myeloblastic myelodysplasia myelodysplastic syndrome myelofibrosis myelogenous myelogram myeloid myeloma myelomatosis myelomonocyte myeloproliferative neoplasm myelosclerosis with myeloid metaplasia